Sema4 Holdings Corp - Ordinary Shares - Class A Stock News
$80.37
6.48%
Nasdaq, Sep 29, 11:15 am EDT.
Market open.
Index
Industry
Sema4 Holdings Corp - Ordinary Shares - Class A Stock News
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C.
GAITHERSBURG, Md.--(BUSINESS WIRE)--Katherine Stueland, CEO of GeneDx, has been named a 2026 Fierce 50 honoree for Health Equity.
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Seattle Children's show hospital-wide rapid genome sequencing accelerates accurate diagnosis and expands access to answers for children.
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx launches a new online offering to expand access to exome testing and help more children and families get answers sooner.
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today reported its financial and operational results for the second quarter of 2026.
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx today announced the appointment of Mark Gardner as President, effective June 15, 2026.
PHILADELPHIA, June 15, 2026 (GLOBE NEWSWIRE) -- On June 4, 2026, Barrack Rodos & Bacine filed a class action lawsuit seeking to represent purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”). Captioned Basma v.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
